Third Straight Plaintiff's Verdict, and Largest to Date, in Accutane Litigation

On Tuesday, a jury in Atlantic City, NJ, ordered the pharmaceutical manufacturer Roche to pay plaintiff Kamie Kendall $10,578,500.00, for injuries caused by its drug Accutane. Ms Kendall developed ulcerative colitis, a form of inflammatory bowel disease (IBD), after taking Accutane. The jury found that Roche failed to warn Ms. Kendall and her physician about the risk of IBD associated with its drug. The $10.5 million compensatory award is the largest in any Accutane case to date.